Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-018622·American Endowment Foundation
Schedule 13G ownership disclosure
CYCLERION THERAPEUTICS INC
Common Stock, no par value · CUSIP: 23255M204
Event date: 2024-12-31
- Filing-level shares
- 133,026
- Percent of class
- 4.91%
- American Endowment Foundation
Shares: 133,026 · Class: 4.91%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-018622
- Form type
- SCHEDULE 13G/A
- Filer
- American Endowment Foundation
- CIK
- CIK 1802579
- Filed
- Feb 12, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership